Hypothalamic BDNF-mTOR signaling promotes hypertension by increasing cardiovascular sensitivity to stress
下丘脑 BDNF-mTOR 信号通过增加心血管对压力的敏感性促进高血压
基本信息
- 批准号:10736248
- 负责人:
- 金额:$ 60.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-21 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Chronic psychological stressors, including work-related stress, poor socioeconomic status and social isolation —
all heightened by recent Covid-19 lockdowns — are major risk factors for hypertension and cardiovascular
disease. Stress-activated regulatory mechanisms that stimulate the sympathetic nervous system to elevate blood
pressure and redistribute blood flow to vital organs have evolved as life-protecting measures. From an
evolutionary perspective, enhancing cardiovascular responses through long-term sensitization of these
mechanisms is advantageous to organisms subjected to repeated stressors. However, in modern society, where
coping with stressful situations rarely requires marked elevations in blood pressure, these actions become
detrimental, as repeated unnecessary overload of the cardiovascular system exerts irreversible cardiac, vascular,
and renal damage. Accordingly, augmented cardiovascular sensitivity to stressors in young, normotensive
individuals is strongly correlated with the risk of becoming hypertensive later in life. Our long-term goal is to
investigate the central mechanisms that determine the magnitude of blood pressure elevations elicited by stress
in order to identify novel anti-hypertensive therapeutic targets. Here, we propose to investigate a novel signaling
cascade mediated by brain-derived neurotrophic factor (BDNF) and mechanistic target of rapamycin (mTOR) in
the paraventricular nucleus of the hypothalamus (PVN), a brain region that plays a key role in orchestrating
neuroendocrine and cardiovascular stress responses. BDNF expression is upregulated in the PVN during stress
in response to increased excitatory input and neuronal activity. We have previously shown that BDNF elicits
important adaptive changes within the PVN to elevate sympathetic activity and blood pressure. Our preliminary
data suggest that BDNF stimulates mTOR, as part of mTOR complex-1 (mTORC1) in PVN neurons, and mTORC1
can fundamentally change neuronal morphology and synaptic connectivity, resulting in elevated neuronal
excitability to augment cardiovascular stress responses and promote hypertension. To test our hypothesis, we
employ a comprehensive array of in vitro patch-clamp studies, neuronal morphology analysis, as well as in vivo
experiments using viral vector-mediated genetic manipulation of BDNF and mTORC1 and telemetric monitoring
of cardiovascular parameters in rats. In Aim 1, we test whether mTORC1 activation in the PVN elevates blood
pressure, augments cardiovascular stress responses, and mediates hypertensive actions of BDNF. In Aim 2, we
determine whether BDNF–mTORC1 signaling regulates structural and functional characteristics of PVN pre-
sympathetic neurons, resulting in enhanced excitability. In Aim 3, we test whether inhibition of BDNF–mTORC1
prevents chronic stress-induced hypertension in borderline hypertensive rats. These studies have the potential
to significantly advance the field by establishing the BDNF–mTORC1 axis as a highly important regulator of
autonomic and cardiovascular function that determines the amplitude of blood pressure elevations during stress
and elicits long-term adaptive mechanisms in the PVN that promote the development of hypertension.
长期的心理压力源,包括与工作有关的压力,社会经济地位差和社会隔离 -
所有最近的Covid-19锁定都提高了 - 是高血压和心血管的主要危险因素
疾病。压力激活的调节机制刺激交感神经系统升高血液
压力和重新分配到重要器官的血流已演变为生命保护措施。从一个
进化观点,通过长期敏感性增强心血管反应
机制对经过重复应激源的生物有利。但是,在现代社会中
应对压力的情况很少需要标记的血压升高,这些动作变为
有害的,由于心血管系统的反复不必要的超负荷施加不可逆的心脏,血管,
和肾脏伤害。彼此之间,对年轻人的压力源的增强心血管敏感性
个体与以后生活中高血压的风险密切相关。我们的长期目标是
研究确定压力引起的血压升高幅度的中心机制
为了确定新型的抗高血压治疗靶标。在这里,我们建议研究一种新的信号
由脑衍生的神经营养因子(BDNF)和雷帕霉素(MTOR)介导的级联反应
下丘脑(PVN)的室室核,这是一个在编排中起关键作用的大脑区域
神经内分泌和心血管应激反应。在压力期间,PVN中更新了BDNF的表达
响应增加的兴奋性输入和神经元活性。我们以前已经表明BDNF引起
PVN内的重要自适应变化以提高交感神经和血压。我们的初步
数据表明,BDNF刺激MTOR,作为PVN神经元中MTOR COVENCES-1(MTORC1)的一部分,MTORC1
可以从根本上改变神经元的形态和突触连通性,从而导致神经元升高
增加心血管应激反应并促进高血压的兴奋性。为了检验我们的假设,我们
采用一系列全面的体外斑块钳研究,神经元形态分析以及体内
使用病毒载体介导的BDNF和MTORC1的遗传操纵以及远程测光监测的实验
大鼠的心血管参数。在AIM 1中,我们测试MTORC1在PVN中的激活是否升高血液
压力,增加心血管应力反应,并介导BDNF的高血压作用。在AIM 2中,我们
确定BDNF-MTORC1信号是否调节PVN前的结构和功能特征
交感神经元,导致兴奋性增强。在AIM 3中,我们测试BDNF – MTORC1的抑制是否
防止慢性应激引起的高血压大鼠的高血压。这些研究具有潜力
通过确定BDNF – MTORC1轴作为非常重要的调节剂来显着推进该领域
自主和心血管功能决定了压力期间血压升高的放大器
并引起PVN中促进高血压发展的长期自适应机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Benedek Erdos的其他基金
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
- 批准号:1019474210194742
- 财政年份:2021
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
- 批准号:1040021110400211
- 财政年份:2021
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
Brain-derived neurotrophic factor: a novel regulator of cardiovascular function in the hypothalamus
脑源性神经营养因子:下丘脑心血管功能的新型调节剂
- 批准号:99034249903424
- 财政年份:2017
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
相似国自然基金
碳网间植入载金MOFs管阵列的三维分子印迹传感器及其对地平类降压药的手性识别研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
碳网间植入载金MOFs管阵列的三维分子印迹传感器及其对地平类降压药的手性识别研究
- 批准号:22274096
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
降压药对细胞内钙空间分布及膜钙电流与血压关系的研究
- 批准号:39370792
- 批准年份:1993
- 资助金额:6.0 万元
- 项目类别:面上项目
降压药转换酶抑制剂对肾脏保护作用及机理的探讨
- 批准号:39170848
- 批准年份:1991
- 资助金额:3.0 万元
- 项目类别:面上项目
血小板心房利钠因子受休及其临床研究
- 批准号:38970362
- 批准年份:1989
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Angiotensin-(1-7) engages hypothalamic arcuate-paraventricular nucleus inhibitory pathways to lower blood pressure
血管紧张素-(1-7) 参与下丘脑弓状室旁核抑制通路来降低血压
- 批准号:1075168210751682
- 财政年份:2023
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
Novel Pharmacological Treatment for Preeclampsia
先兆子痫的新型药物治疗
- 批准号:1075898010758980
- 财政年份:2023
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 细胞外容量、利尿钠肽、症状和心血管结局变化的关系
- 批准号:1036668410366684
- 财政年份:2022
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment
通过图像引导超声空化和机械治疗对肿瘤微环境进行敏化的新范例,用于靶向 HCC 治疗
- 批准号:1051681410516814
- 财政年份:2022
- 资助金额:$ 60.27万$ 60.27万
- 项目类别:
In Vivo Characterizations of Retinal Hemodynamics
视网膜血流动力学的体内表征
- 批准号:1050349710503497
- 财政年份:2022
- 资助金额:$ 60.27万$ 60.27万
- 项目类别: